Summit Securities Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-136
Closed -$653K 508
2020
Q1
$653K Buy
136
+86
+172% +$4K 0.11% 144
2019
Q4
$235K Buy
+50
New +$2.21K 0.02% 383

Other funds holding RARX